Homozygous Familial Hypercholesterolemia Animation

The visual science of a first-in-class treatment in Homozygous Familial Hypercholesterolemia (HoFH).

This excerpt is taken from our 3D animation work for a biopharmaceutical company that developed an FDA-approved orphan drug, aimed at treating the rare genetic disease homozygous familial hypercholesterolemia (HoFH).

This video explores the activity within the body of a person affected with HoFH — explaining the normal and abnormal functions of LDL-C.


3D animations
Multiple Language Videos
3D Illustrations - online, banner & brochure


Aegerion Pharmaceuticals


Juxtapid (USA) & Lojuxta (EU)

  • Familial Hypercholesterolemia Animation
HoFH medical animation
HoFH 3D animation

What is Homozygous
Familial Hypercholesterolemia (HoFH)

Familial hypercholesterolemia (FH), an autosomal codominant disease, is characterized by high levels of LDL cholesterol and a high incidence of coronary artery disease (CAD).

Homozygous Familial Hypercholesterolemia, or HoFH, is a rare genetic lipid disorder usually caused by defects in the low-density lipoprotein, or LDL, receptor genes, inherited from both parents, resulting in impaired or total loss of function in the LDL receptor.

It has been great working with you and we really appreciate all your work to make the videos become a reality.

Senior Director Business Development & US Marketing, Rare Disease, Aegerion Pharmaceuticals, Massachusetts, USA

Related Work

Need help with a project?

Get in touch and start your creative journey.

Contact Us

New Business


+44 (0) 20 7183 9412 - UK

+1 646 568 4358 - USA


Suite 6, Claremont House,
22-24, Claremont Rd.,
Surbiton, Surrey,